The rise in the circulatory inflammatory cytokines interleukin-1β, interleukin-6 and tumor necrosis factor-α and increase in hepatic stiffness and steatosis in battery factory workers after chronic exposure to lead were reduced following chelation therapy with intravenous CaNa2EDTA (62). This evidence concerns the gene IL6 and steatosis.